$CEWATER

🧪 CONCORD BIOTECH SUCCESSFULLY CLEARS ANVISA INSPECTION • 🇧🇷 Successfully completed ANVISA (Brazilian Health Regulatory Agency) inspection at its Limbasi API manufacturing facility • 📅 Inspection was conducted from June 8–12, 2026 • ✅ Inspection concluded successfully, reaffirming compliance with global quality standards • 🌍 Strengthens Concord Biotech's regulatory footprint and international expansion strategy • 💊 Enhances access to the Brazilian pharmaceutical market, one of the world's largest healthcare markets 🟢 Impact: Positive (Supports export growth, regulatory credibility and expansion of API business across global markets)